Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 472.57% and ...

Lilly's Omvoh receives US FDA approval to treat Crohn's disease in adults: Indianapolis Friday, January 17, 2025, 12:00 Hrs [IST] Eli Lilly and Company announced that the US Food ...

More than half (53%) of patients reached remission after one year of Omvoh treatment and 46% experienced healing of the ...

Approval was based on results of the VIVID-1 study, which found that Omvoh demonstrated significant clinical remission and ...

The FDA has approved Omvoh for the treatment of moderately to severely active Crohn’s disease, making it the second ...

Mirikizumab is a humanized immunoglobulin G4 monoclonal antibody that selectively binds to the p19 subunit of human interleukin (IL)-23.

An FDA advisory committee on Friday voted 8 to 4 in favor of Japan-based Seikagaku's condoliase injection for the treatment ...

Antarctic sea ice rebounded in December after a long period of record lows, US scientists said, giving pause to speculation that Earth's frozen continent could be undergoing a permanent change ...

From weight loss to cancer drugs, subcutaneous injections are popular with patients for their convenience, potentially freeing them from cumbersome intravenous infusions. Subcutaneous versions of ...